NDC 0078-0501

Exelon

Rivastigmine

Exelon is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Rivastigmine.

Product ID0078-0501_2e2200d5-3ab6-4b69-a1e0-12d84a4a7b43
NDC0078-0501
Product TypeHuman Prescription Drug
Proprietary NameExelon
Generic NameRivastigmine
Dosage FormPatch, Extended Release
Route of AdministrationTRANSDERMAL
Marketing Start Date2007-07-06
Marketing CategoryNDA / NDA
Application NumberNDA022083
Labeler NameNovartis Pharmaceuticals Corporation
Substance NameRIVASTIGMINE
Active Ingredient Strength5 mg/24h
Pharm ClassesCholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0078-0501-15

30 PATCH in 1 CARTON (0078-0501-15) > 24 h in 1 PATCH (0078-0501-61)
Marketing Start Date2007-07-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0078-0501-61 [00078050161]

Exelon PATCH, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA022083
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-09-14

NDC 0078-0501-15 [00078050115]

Exelon PATCH, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA022083
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-07-06

Drug Details

Active Ingredients

IngredientStrength
RIVASTIGMINE4.6 mg/24h

OpenFDA Data

SPL SET ID:07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 725021
  • 725023
  • 1308571
  • 725105
  • 1308569
  • 751302
  • Pharmacological Class

    • Cholinesterase Inhibitor [EPC]
    • Cholinesterase Inhibitors [MoA]
    • Cholinesterase Inhibitor [EPC]
    • Cholinesterase Inhibitors [MoA]

    NDC Crossover Matching brand name "Exelon" or generic name "Rivastigmine"

    NDCBrand NameGeneric Name
    0078-0323Exelonrivastigmine tartrate
    0078-0324Exelonrivastigmine tartrate
    0078-0325Exelonrivastigmine tartrate
    0078-0326Exelonrivastigmine tartrate
    0078-0501Exelonrivastigmine
    0078-0502Exelonrivastigmine
    0078-0503Exelonrivastigmine
    21695-357ExelonExelon
    0378-9070Rivastigminerivastigmine
    0378-9071Rivastigminerivastigmine
    0378-9072Rivastigminerivastigmine
    0781-7304Rivastigminerivastigmine
    0781-7309Rivastigminerivastigmine
    0781-7313Rivastigminerivastigmine
    16714-115RivastigmineRivastigmine

    Trademark Results [Exelon]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EXELON
    EXELON
    97977525 not registered Live/Pending
    Exelon Corporation
    2021-11-05
    EXELON
    EXELON
    97977523 not registered Live/Pending
    Exelon Corporation
    2021-11-05
    EXELON
    EXELON
    97110038 not registered Live/Pending
    Exelon Corporation
    2021-11-05
    EXELON
    EXELON
    97110036 not registered Live/Pending
    Exelon Corporation
    2021-11-05
    EXELON
    EXELON
    86776336 5508909 Live/Registered
    Exelon Corporation
    2015-10-02
    EXELON
    EXELON
    86776333 5508908 Live/Registered
    Exelon Corporation
    2015-10-02
    EXELON
    EXELON
    86302338 4671120 Live/Registered
    Exelon Corporation
    2014-06-06
    EXELON
    EXELON
    85982666 not registered Dead/Abandoned
    Exelon Corporation
    2012-05-24
    EXELON
    EXELON
    85982665 not registered Dead/Abandoned
    Exelon Corporation
    2012-05-24
    EXELON
    EXELON
    85980324 4445212 Live/Registered
    Exelon Corporation
    2012-05-24
    EXELON
    EXELON
    85980323 4445211 Live/Registered
    Exelon Corporation
    2012-05-24
    EXELON
    EXELON
    85634507 not registered Dead/Abandoned
    Exelon Corporation
    2012-05-24

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.